Clinuvel Pharmaceuticals Dividends and Buybacks
Dividend criteria checks 0/6
Clinuvel Pharmaceuticals is a dividend paying company with a current yield of 0.38%.
Key information
0.4%
Dividend yield
0.1%
Buyback Yield
| Total Shareholder Yield | 0.5% |
| Future Dividend Yield | 0.9% |
| Dividend Growth | 24.4% |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | AU$0.050 |
| Payout ratio | 7% |
Recent dividend and buyback updates
Recent updates
If EPS Growth Is Important To You, Clinuvel Pharmaceuticals (ASX:CUV) Presents An Opportunity
Aug 11
Calculating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jun 27Is Now The Time To Put Clinuvel Pharmaceuticals (ASX:CUV) On Your Watchlist?
May 09Estimating The Intrinsic Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Mar 24An Intrinsic Calculation For Clinuvel Pharmaceuticals Limited (ASX:CUV) Suggests It's 41% Undervalued
Nov 18Increases to Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Compensation Might Cool off for now
Oct 20Is Clinuvel Pharmaceuticals Limited (ASX:CUV) Trading At A 21% Discount?
Jul 30Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Could Be 27% Below Their Intrinsic Value Estimate
Feb 27Does Clinuvel Pharmaceuticals (ASX:CUV) Deserve A Spot On Your Watchlist?
Dec 14This Is The Reason Why We Think Clinuvel Pharmaceuticals Limited's (ASX:CUV) CEO Might Be Underpaid
Nov 03A Look At The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Sep 23Here's Why I Think Clinuvel Pharmaceuticals (ASX:CUV) Might Deserve Your Attention Today
Jul 23With EPS Growth And More, Clinuvel Pharmaceuticals (ASX:CUV) Is Interesting
Apr 10Have Insiders Sold Clinuvel Pharmaceuticals Limited (ASX:CUV) Shares Recently?
Mar 06Earnings Miss: Clinuvel Pharmaceuticals Limited Missed EPS By 41% And Analysts Are Revising Their Forecasts
Feb 27What Is The Ownership Structure Like For Clinuvel Pharmaceuticals Limited (ASX:CUV)?
Feb 20Clinuvel Pharmaceuticals (ASX:CUV) Shareholders Have Enjoyed A Whopping 648% Share Price Gain
Feb 01Estimating The Fair Value Of Clinuvel Pharmaceuticals Limited (ASX:CUV)
Jan 14We Wouldn't Rely On Clinuvel Pharmaceuticals's (ASX:CUV) Statutory Earnings As A Guide
Dec 28
Clinuvel Pharmaceuticals Limited's (ASX:CUV) Stock's On An Uptrend: Are Strong Financials Guiding The Market?
Dec 10What You Need To Know About Clinuvel Pharmaceuticals Limited's (ASX:CUV) Investor Composition
Nov 21Stability and Growth of Payments
Fetching dividends data
Stable Dividend: CUV is not paying a notable dividend for the Australian market, therefore no need to check if payments are stable.
Growing Dividend: CUV is not paying a notable dividend for the Australian market, therefore no need to check if payments are increasing.
Dividend Yield vs Market
| Clinuvel Pharmaceuticals Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (CUV) | 0.4% |
| Market Bottom 25% (AU) | 2.6% |
| Market Top 25% (AU) | 6.0% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (CUV) (up to 3 years) | 0.9% |
Notable Dividend: CUV's dividend (0.38%) isn’t notable compared to the bottom 25% of dividend payers in the Australian market (2.63%).
High Dividend: CUV's dividend (0.38%) is low compared to the top 25% of dividend payers in the Australian market (6.01%).
Earnings Payout to Shareholders
Earnings Coverage: CUV is not paying a notable dividend for the Australian market.
Cash Payout to Shareholders
Cash Flow Coverage: CUV is not paying a notable dividend for the Australian market.